These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10805111)

  • 1. Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444.
    Oyen WJ; Boerman OC; Brouwers FM; Barrett JA; Verheugt FW; Ruiter DJ; Corstens FH; van der Meer JW
    Eur J Nucl Med; 2000 Apr; 27(4):392-9. PubMed ID: 10805111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.
    Brouwers FM; Oyen WJ; Boerman OC; Barrett JA; Verheugt FW; Corstens FH; Van der Meer JW
    Clin Nucl Med; 2003 Jun; 28(6):480-4. PubMed ID: 12911097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model.
    Scharn DM; Oyen WJ; Klemm PL; Wijnen MH; vanderVliet JA
    Cardiovasc Surg; 2002 Dec; 10(6):566-9. PubMed ID: 12453688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis.
    Rouzet F; Dominguez Hernandez M; Hervatin F; Sarda-Mantel L; Lefort A; Duval X; Louedec L; Fantin B; Le Guludec D; Michel JB
    Circulation; 2008 Feb; 117(6):781-9. PubMed ID: 18227388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
    Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.
    Klem JA; Schaffer JV; Crane PD; Barrett JA; Henry GA; Canestri L; Ezekowitz MD
    J Nucl Cardiol; 2000; 7(4):359-64. PubMed ID: 10958278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.
    Fang W; He J; Kim YS; Zhou Y; Liu S
    Bioconjug Chem; 2011 Aug; 22(8):1715-22. PubMed ID: 21780818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis.
    Brouwer CP; Gemmel FF; Welling MM
    Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):442-50. PubMed ID: 20823811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
    Mousa SA; Bozarth JM; Edwards S; Carroll T; Barrett J
    Coron Artery Dis; 1998; 9(2-3):131-41. PubMed ID: 9647415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bacterial endocarditis with technetium-99m-labeled antistaphylococcal antibody.
    Huang JT; Raiszadeh M; Sakimura I; Montgomerie JZ; Harwig JF
    J Nucl Med; 1980 Aug; 21(8):783-6. PubMed ID: 7400835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m stannous pyrophosphate imaging of experimental infective endocarditis.
    Riba AL; Downs J; Thakur ML; Gottschalk A; Andriole VT; Zaret BL
    Circulation; 1978 Jul; 58(1):111-9. PubMed ID: 656183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
    Lister-James J; Knight LC; Maurer AH; Bush LR; Moyer BR; Dean RT
    J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.
    Lister-James J; Vallabhajosula S; Moyer BR; Pearson DA; McBride BJ; De Rosch MA; Bush LR; Machac J; Dean RT
    J Nucl Med; 1997 Jan; 38(1):105-11. PubMed ID: 8998163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
    Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
    Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model.
    Mitchel J; Waters D; Lai T; White M; Alberghini T; Salloum A; Knibbs D; Li D; Heller GV
    Circulation; 2000 Apr; 101(14):1643-6. PubMed ID: 10758044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic evaluation of experimental chronic osteomyelitis.
    Dams ET; Nijhof MW; Boerman OC; Laverman P; Storm G; Buma P; Lemmens JA; van der Meer JW; Corstens FH; Oyen WJ
    J Nucl Med; 2000 May; 41(5):896-902. PubMed ID: 10809206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
    Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
    J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.
    Dams ET; Becker MJ; Oyen WJ; Boerman OC; Storm G; Laverman P; de Marie S; van der Meer JW; Bakker-Woudenberg IA; Corstens FH
    J Nucl Med; 1999 Dec; 40(12):2066-72. PubMed ID: 10616887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
    Liu CZ; Huang HY; Tsai PJ; Shih MH
    Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.